PDB Short entry for 1ZKC HEADER ISOMERASE 02-MAY-05 1ZKC TITLE CRYSTAL STRUCTURE OF THE CYCLOPHILN_RING DOMAIN OF HUMAN TITLE 2 PEPTIDYLPROLYL ISOMERASE (CYCLOPHILIN)-LIKE 2 ISOFORM B COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE LIKE 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SEQUENCE DATABANK RESIDUES 20-197; COMPND 5 SYNONYM: PPIASE, ROTAMASE, CYCLOPHILIN-60, CYCLOPHILIN-LIKE PROTEIN COMPND 6 CYP-60, CYCLOPHILIN-RING DOMAIN; COMPND 7 EC: 5.2.1.8; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPIL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28-LIC KEYWDS CIS-TRANS ISOMERIZATION, PEPTIDYLPROLYL ISOMERASE, PROTEIN-FOLDING, KEYWDS 2 STRUCTURAL GENOMICS CONSORTIUM, SGC, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.R.WALKER,T.DAVIS,E.M.NEWMAN,F.MACKENZIE,J.WEIGELT,M.SUNDSTROM, AUTHOR 2 C.ARROWSMITH,A.EDWARDS,A.BOCHKAREV,S.DHE-PAGANON,STRUCTURAL GENOMICS AUTHOR 3 CONSORTIUM (SGC) REVDAT 6 23-AUG-23 1ZKC 1 REMARK SEQADV LINK REVDAT 5 07-FEB-18 1ZKC 1 JRNL REVDAT 4 24-FEB-09 1ZKC 1 VERSN REVDAT 3 05-DEC-06 1ZKC 1 DBREF SEQADV REVDAT 2 24-JAN-06 1ZKC 1 JRNL REVDAT 1 16-AUG-05 1ZKC 0 JRNL AUTH T.L.DAVIS,J.R.WALKER,V.CAMPAGNA-SLATER,P.J.FINERTY, JRNL AUTH 2 R.PARAMANATHAN,G.BERNSTEIN,F.MACKENZIE,W.TEMPEL,H.OUYANG, JRNL AUTH 3 W.H.LEE,E.Z.EISENMESSER,S.DHE-PAGANON JRNL TITL STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF THE HUMAN JRNL TITL 2 CYCLOPHILIN FAMILY OF PEPTIDYL-PROLYL ISOMERASES. JRNL REF PLOS BIOL. V. 8 00439 2010 JRNL REFN ESSN 1545-7885 JRNL PMID 20676357 JRNL DOI 10.1371/JOURNAL.PBIO.1000439 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 54423 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.158 REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2907 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2435 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 59.13 REMARK 3 BIN R VALUE (WORKING SET) : 0.2260 REMARK 3 BIN FREE R VALUE SET COUNT : 136 REMARK 3 BIN FREE R VALUE : 0.3230 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2938 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 8 REMARK 3 SOLVENT ATOMS : 581 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12000 REMARK 3 B22 (A**2) : 0.12000 REMARK 3 B33 (A**2) : -0.17000 REMARK 3 B12 (A**2) : 0.06000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.105 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.084 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.050 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.247 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3014 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4064 ; 1.333 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 370 ; 5.686 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 148 ;29.512 ;23.243 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 508 ;11.288 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;14.919 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 430 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2328 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1406 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2073 ; 0.309 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 479 ; 0.153 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 82 ; 0.180 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 43 ; 0.201 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1899 ; 2.064 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2976 ; 2.713 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1250 ; 4.427 ; 5.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1088 ; 4.931 ; 7.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 3149 ; 3.495 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 582 ; 4.278 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2946 ; 3.484 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1ZKC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-MAY-05. REMARK 100 THE DEPOSITION ID IS D_1000032816. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57395 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 31.8600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.47900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.720 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1IIP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8M POTASSIUM SODIUM TARTRATE REMARK 280 TETRAHYDRATE, 0.1M HEPES, PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K, PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.26333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 134.52667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 134.52667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 67.26333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 261 REMARK 465 GLY A 262 REMARK 465 SER A 263 REMARK 465 SER A 264 REMARK 465 HIS A 265 REMARK 465 HIS A 266 REMARK 465 HIS A 267 REMARK 465 HIS A 268 REMARK 465 HIS A 269 REMARK 465 HIS A 270 REMARK 465 MET B 261 REMARK 465 GLY B 262 REMARK 465 SER B 263 REMARK 465 SER B 264 REMARK 465 HIS B 265 REMARK 465 HIS B 266 REMARK 465 HIS B 267 REMARK 465 HIS B 268 REMARK 465 HIS B 269 REMARK 465 HIS B 270 REMARK 465 SER B 271 REMARK 465 SER B 272 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 343 NH1 ARG B 377 1.87 REMARK 500 CE1 TYR A 438 O HOH A 883 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH1 ARG A 277 OE2 GLU A 343 4545 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 309 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 328 -88.29 -131.53 REMARK 500 ARG A 377 -100.15 -126.39 REMARK 500 CYS A 387 85.13 -155.23 REMARK 500 PHE B 328 -87.27 -129.02 REMARK 500 ARG B 377 -102.17 -125.58 REMARK 500 CYS B 387 82.00 -157.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 638 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME B 639 DBREF 1ZKC A 280 457 UNP Q13356 PPIL2_HUMAN 280 457 DBREF 1ZKC B 280 457 UNP Q13356 PPIL2_HUMAN 280 457 SEQADV 1ZKC MET A 261 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC GLY A 262 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER A 263 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER A 264 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS A 265 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS A 266 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS A 267 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS A 268 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS A 269 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS A 270 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER A 271 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER A 272 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC GLY A 273 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC LEU A 274 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC VAL A 275 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC PRO A 276 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC ARG A 277 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC GLY A 278 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER A 279 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC MET B 261 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC GLY B 262 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER B 263 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER B 264 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS B 265 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS B 266 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS B 267 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS B 268 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS B 269 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC HIS B 270 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER B 271 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER B 272 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC GLY B 273 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC LEU B 274 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC VAL B 275 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC PRO B 276 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC ARG B 277 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC GLY B 278 UNP Q13356 CLONING ARTIFACT SEQADV 1ZKC SER B 279 UNP Q13356 CLONING ARTIFACT SEQRES 1 A 197 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 197 LEU VAL PRO ARG GLY SER GLY TYR VAL ARG LEU HIS THR SEQRES 3 A 197 ASN LYS GLY ASP LEU ASN LEU GLU LEU HIS CYS ASP LEU SEQRES 4 A 197 THR PRO LYS THR CYS GLU ASN PHE ILE ARG LEU CYS LYS SEQRES 5 A 197 LYS HIS TYR TYR ASP GLY THR ILE PHE HIS ARG SER ILE SEQRES 6 A 197 ARG ASN PHE VAL ILE GLN GLY GLY ASP PRO THR GLY THR SEQRES 7 A 197 GLY THR GLY GLY GLU SER TYR TRP GLY LYS PRO PHE LYS SEQRES 8 A 197 ASP GLU PHE ARG PRO ASN LEU SER HIS THR GLY ARG GLY SEQRES 9 A 197 ILE LEU SER MET ALA ASN SER GLY PRO ASN SER ASN ARG SEQRES 10 A 197 SER GLN PHE PHE ILE THR PHE ARG SER CYS ALA TYR LEU SEQRES 11 A 197 ASP LYS LYS HIS THR ILE PHE GLY ARG VAL VAL GLY GLY SEQRES 12 A 197 PHE ASP VAL LEU THR ALA MET GLU ASN VAL GLU SER ASP SEQRES 13 A 197 PRO LYS THR ASP ARG PRO LYS GLU GLU ILE ARG ILE ASP SEQRES 14 A 197 ALA THR THR VAL PHE VAL ASP PRO TYR GLU GLU ALA ASP SEQRES 15 A 197 ALA GLN ILE ALA GLN GLU ARG LYS THR GLN LEU LYS VAL SEQRES 16 A 197 ALA PRO SEQRES 1 B 197 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 197 LEU VAL PRO ARG GLY SER GLY TYR VAL ARG LEU HIS THR SEQRES 3 B 197 ASN LYS GLY ASP LEU ASN LEU GLU LEU HIS CYS ASP LEU SEQRES 4 B 197 THR PRO LYS THR CYS GLU ASN PHE ILE ARG LEU CYS LYS SEQRES 5 B 197 LYS HIS TYR TYR ASP GLY THR ILE PHE HIS ARG SER ILE SEQRES 6 B 197 ARG ASN PHE VAL ILE GLN GLY GLY ASP PRO THR GLY THR SEQRES 7 B 197 GLY THR GLY GLY GLU SER TYR TRP GLY LYS PRO PHE LYS SEQRES 8 B 197 ASP GLU PHE ARG PRO ASN LEU SER HIS THR GLY ARG GLY SEQRES 9 B 197 ILE LEU SER MET ALA ASN SER GLY PRO ASN SER ASN ARG SEQRES 10 B 197 SER GLN PHE PHE ILE THR PHE ARG SER CYS ALA TYR LEU SEQRES 11 B 197 ASP LYS LYS HIS THR ILE PHE GLY ARG VAL VAL GLY GLY SEQRES 12 B 197 PHE ASP VAL LEU THR ALA MET GLU ASN VAL GLU SER ASP SEQRES 13 B 197 PRO LYS THR ASP ARG PRO LYS GLU GLU ILE ARG ILE ASP SEQRES 14 B 197 ALA THR THR VAL PHE VAL ASP PRO TYR GLU GLU ALA ASP SEQRES 15 B 197 ALA GLN ILE ALA GLN GLU ARG LYS THR GLN LEU LYS VAL SEQRES 16 B 197 ALA PRO HET BME A 638 4 HET BME B 639 4 HETNAM BME BETA-MERCAPTOETHANOL FORMUL 3 BME 2(C2 H6 O S) FORMUL 5 HOH *581(H2 O) HELIX 1 1 THR A 300 LYS A 313 1 14 HELIX 2 2 CYS A 387 ASP A 391 5 5 HELIX 3 3 GLY A 403 VAL A 413 1 11 HELIX 4 4 TYR A 438 ALA A 456 1 19 HELIX 5 5 THR B 300 LYS B 313 1 14 HELIX 6 6 CYS B 387 ASP B 391 5 5 HELIX 7 7 GLY B 403 ASN B 412 1 10 HELIX 8 8 TYR B 438 ALA B 456 1 19 SHEET 1 A 8 PHE A 321 ILE A 325 0 SHEET 2 A 8 VAL A 329 GLY A 332 -1 O GLN A 331 N ARG A 323 SHEET 3 A 8 PHE A 380 THR A 383 -1 O PHE A 380 N GLY A 332 SHEET 4 A 8 ILE A 365 MET A 368 -1 N SER A 367 O PHE A 381 SHEET 5 A 8 ILE A 396 GLY A 402 -1 O PHE A 397 N LEU A 366 SHEET 6 A 8 GLY A 289 LEU A 295 -1 N GLU A 294 O ARG A 399 SHEET 7 A 8 GLY A 280 THR A 286 -1 N LEU A 284 O LEU A 291 SHEET 8 A 8 ILE A 428 VAL A 435 -1 O ASP A 429 N HIS A 285 SHEET 1 B 9 GLY B 280 THR B 286 0 SHEET 2 B 9 GLY B 289 LEU B 295 -1 O LEU B 293 N VAL B 282 SHEET 3 B 9 ILE B 396 GLY B 402 -1 O VAL B 401 N ASN B 292 SHEET 4 B 9 ILE B 365 MET B 368 -1 N LEU B 366 O PHE B 397 SHEET 5 B 9 PHE B 380 THR B 383 -1 O PHE B 381 N SER B 367 SHEET 6 B 9 VAL B 329 GLY B 332 -1 N ILE B 330 O ILE B 382 SHEET 7 B 9 THR B 319 ILE B 325 -1 N ARG B 323 O GLN B 331 SHEET 8 B 9 ARG B 427 VAL B 435 -1 O ILE B 428 N THR B 319 SHEET 9 B 9 GLY B 280 THR B 286 -1 N ARG B 283 O THR B 432 SSBOND 1 CYS A 297 CYS A 304 1555 1555 2.09 LINK SG CYS A 387 S2 BME A 638 1555 1555 2.16 LINK SG CYS B 387 S2 BME B 639 1555 1555 2.06 SITE 1 AC1 5 ASN A 327 ARG A 385 SER A 386 CYS A 387 SITE 2 AC1 5 VAL A 455 SITE 1 AC2 6 ASN B 327 PHE B 328 ARG B 385 SER B 386 SITE 2 AC2 6 CYS B 387 VAL B 455 CRYST1 65.028 65.028 201.790 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015378 0.008878 0.000000 0.00000 SCALE2 0.000000 0.017757 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004956 0.00000